Skip to main content
ClinicalTrials.govcontrolled

A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma

ClinicalTrials.gov study NCT06799026. IPD Sharing: YES. Countries: 1. Publications: 0.

ShareScore

28/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship
16
Harmonization
8
Access
0
Reuse readiness
0
Engagement
4

Topics